Objectives Economic evaluations of vaccines should accurately represent all relevant
economic and health consequences of vaccination, including losses due to adverse events …

Purpose The aim of this study was to systematically review the cost-effectiveness of HPV
vaccination in Asia. Methods We performed a systematic review of papers indexed in …

Objective To examine the epidemiological and economic impact of a nine‐valent
(nonavalent) human papillomavirus (HPV) 6/11/16/18/31/33/45/52/58 vaccine programme …

Abstract Globally, gender-neutral Human Papillomavirus (HPV) vaccination programmes are
gaining traction. Although cervical cancer remains the most prevalent, other HPV-related …

Background Around 70% of cervical cancers are caused by Types 16 and 18 of human
papillomavirus (HPV). Vaccines against HPV have been shown to be safe and effective in …

Cervical cancer (CC) is the fourth most common malignancy in women, with a global
estimate of 570,000 new cases and 311,000 deaths in 2018.[1] Approximately 27,000 anal …

Background: Cervical cancer is a significant health issue in Indonesia, with many patients
diagnosed with advanced-stage cancer. Human papillomavirus (HPV) vaccination has long …

Over the past few years, many innovative vaccines became available that offer protection for
diseases which have never been prevented before. While there are several factors that …

Methods: Fully subsidised HPV vaccinations were offered to all Secondary 1 female
students on an opt-in basis, starting as a rollout dose in 2019. One-time catchup vaccination …

Pada tahun 2012 di dunia diperkirakan 270.000 wanita mengalami kematian akibat kanker
serviks. 99, 7% kanker serviks diakibatkan oleh Human Papilloma Virus (HPV). Program …